Total Payments
$3,150
2023 Payments
$1,645
Companies
24
Transactions
158
Medicare Patients
1,920
Medicare Billing
$372,225
Payment Breakdown by Category
Food & Beverage$3,150 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,150 | 158 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $565.77 | 48 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $341.05 | 8 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $337.91 | 7 | $0 (2023) |
| PFIZER INC. | $334.25 | 20 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $318.51 | 19 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $189.95 | 5 | $0 (2021) |
| GRT US Holding, Inc. | $144.69 | 8 | $0 (2022) |
| Lundbeck LLC | $144.21 | 3 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $135.75 | 7 | $0 (2023) |
| Amgen Inc. | $121.59 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,645 | 73 | ABBVIE INC. ($362.91) |
| 2022 | $991.32 | 67 | Biohaven Pharmaceutical Holding Company Ltd. ($318.51) |
| 2021 | $513.30 | 18 | Biohaven Pharmaceuticals, Inc. ($189.95) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: PAIN | ||||||
| 09/06/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.36 | General |
| Category: NEUROLOGY | ||||||
| 08/29/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: SLEEP MEDICINE | ||||||
| 08/24/2023 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $39.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/21/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: PAIN | ||||||
| 08/21/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/15/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: INSOMNIA | ||||||
| 08/10/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: PAIN | ||||||
| 08/07/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: Neurology | ||||||
| 08/04/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $105.63 | General |
| Category: NEUROLOGY | ||||||
| 08/01/2023 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 07/25/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: PAIN | ||||||
| 07/20/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: INSOMNIA | ||||||
| 07/12/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: PAIN | ||||||
| 07/10/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: PAIN | ||||||
| 06/28/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $135.74 | General |
| Category: Central Nervous System | ||||||
| 06/28/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 114 | 147 | $46,843 | $9,753 |
| 2022 | 6 | 573 | 1,165 | $452,668 | $95,622 |
| 2021 | 6 | 638 | 1,673 | $650,519 | $148,774 |
| 2020 | 7 | 595 | 1,311 | $507,403 | $118,076 |
Total Patients
1,920
Total Services
4,296
Medicare Billing
$372,225
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 99 | $37,571 | $7,804 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,392 | $1,184 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $3,473 | $673.28 | 19.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 23 | 24 | $408.00 | $91.92 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 778 | $295,251 | $61,183 | 20.7% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 59 | 73 | $54,750 | $17,370 | 31.7% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 39 | 42 | $25,200 | $8,134 | 32.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 90 | 113 | $67,800 | $6,911 | 10.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 28 | $7,480 | $1,554 | 20.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 105 | 131 | $2,186 | $471.84 | 21.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 194 | 759 | $246,675 | $63,698 | 25.8% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 132 | 299 | $179,400 | $57,421 | 32.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 137 | 327 | $196,200 | $19,532 | 10.0% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 24 | 29 | $21,750 | $6,241 | 28.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 28 | 30 | $2,601 | $1,007 | 38.7% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 123 | 229 | $3,893 | $875.65 | 22.5% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 91 | 180 | $108,000 | $35,404 | 32.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 127 | 387 | $114,945 | $27,554 | 24.0% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 63 | 88 | $70,884 | $21,002 | 29.6% |
| 80307 | Testing for presence of drug | Office | 2020 | 108 | 267 | $160,200 | $16,400 | 10.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 113 | 251 | $44,476 | $12,336 | 27.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 76 | 104 | $8,320 | $5,258 | 63.2% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 17 | 34 | $578.00 | $121.32 | 21.0% |
About Catherine Breen, PA-C
Catherine Breen, PA-C is a Physical Therapist healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922179266.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Catherine Breen, PA-C has received a total of $3,150 in payments from pharmaceutical and medical device companies, with $1,645 received in 2023. These payments were reported across 158 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,150).
As a Medicare-enrolled provider, Breen has provided services to 1,920 Medicare beneficiaries, totaling 4,296 services with total Medicare billing of $372,225. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Therapist
- Other Specialties Physical Therapist, Medical
- Location Austin, TX
- Active Since 11/10/2006
- Last Updated 08/16/2022
- Taxonomy Code 225100000X
- Entity Type Individual
- NPI Number 1922179266
Products in Payments
- NURTEC ODT (Drug) $807.50
- QULIPTA (Drug) $357.77
- AJOVY (Biological) $202.17
- XYWAV (Drug) $173.74
- RYLAZE (Drug) $167.31
- Qutenza (Drug) $144.69
- VYEPTI (Biological) $144.21
- QUVIVIQ (Drug) $135.75
- Austedo XR (Drug) $135.74
- Aimovig (Biological) $121.59
- UBRELVY (Drug) $118.70
- BOTOX (Biological) $89.30
- Trudhesa (Drug) $87.83
- EMGALITY (Drug) $69.06
- Movantik (Drug) $64.13
- WAKIX (Drug) $35.89
- REYVOW (Drug) $35.21
- Nucynta (Drug) $34.50
- ZTLido (Drug) $28.70
- Durolane (Device) $24.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Therapist Doctors in Austin
Mrs. Su Lim, Pt, PT
Physical Therapist
Physical Therapist
Mr. Benjamin Morgan, Pt, PT
Physical Therapist
Physical Therapist
Miss. Erin Harre-Arnold, Pt, PT
Physical Therapist
Physical Therapist
Mr. Robert Whalin, M.s. P.t, M.S. P.T
Physical Therapist
Physical Therapist
Jon Hupp, Pt, Mtc, Cert. Mdt, PT, MTC, CERT. MDT
Physical Therapist
Physical Therapist
Mrs. Kate Burke, Pt, PT
Physical Therapist
Physical Therapist